Recent Posts - page 2
-
Christmas 2020: Hope and cheer for thyroid patients
It’s been quite a year, so we send you good cheer. This season may be a socially-distanced experience for many of you, but still, you are not alone. We’re stronger together. We’re going to keep advancing thyroid science & policy,… Read More ›
-
Ingbar and Braverman’s historic study of LT4 monotherapy
As part of my post on “The thyroid gland is a T3 shield,” I reviewed a research article by Ingbar and team from 1982. Wow. What a treasure. The title of this article is “Elevated serum thyroxine concentration in patients… Read More ›
-
Reverse T3 in the context of health status, dosages, and thyroid levels
A collection of research graphs and quotations showing diverse Reverse T3 levels coexisting with health, in various illnesses, and alongside various T3 and T4 levels.
-
Gullo: LT4 monotherapy and thyroid loss invert FT3 and FT4 per unit of TSH
In 2011, Gullo’s research team published a landmark study in thyroid therapy titled “Levothyroxine Monotherapy Cannot Guarantee Euthyroidism in All Athyreotic Patients.” Gullo and colleagues examined the TSH, FT3 and FT4 levels and the FT3:FT4 ratios of 1,811 thyroidless patients… Read More ›
-
Normal FT3:FT4 thyroid hormone ratios in large populations
A normal ratio of Free T3 (FT3) to Free T4 (FT4) thyroid hormones appears to be a basic principle in thyroid hormone economy when no thyroid hormone dosing and no disease interfere. When measured in pmol/L, the ratio is consistent… Read More ›
-
Prevalence rates for 10 chronic disorders at various FT4, TSH and FT3 levels
Which FT3, FT4 and TSH levels have the highest and lowest prevalence rates for 10 common health disorders? Hypertension Hyperlipidemia (high cholesterol) Depression Diabetes Coronary artery disease Heart failure Atrial fibrillation Peripheral vascular disease Renal failure (kidney failure) Dementia Is… Read More ›
-
Anderson, 2020: Thyroid hormones and atrial fibrillation
Atrial fibrillation is a cardiac rhythm disorder that significantly elevates the risk of stroke as well as stroke severity. Thyroid hormone excess caused by hyperthyroidism is often named as one of the risk factors for atrial fibrillation. However, it does… Read More ›
-
Mimicry: The idol of T3-T4 combo therapy 2004-2014
They say that history is written by the victors. Not always. Sometimes histories are written by advocates for the oppressed and disenfranchised. A common theme on our website is the need to see current practices and thyroid therapy challenges in… Read More ›
Featured Categories
Therapy paradigms ›
-
Mimicry: The idol of T3-T4 combo therapy 2004-2014
September 10, 2020
-
The foundations of synthetic T3-T4 therapy in the 1990s
September 1, 2020
-
Four definitions of thyroid status
March 28, 2020
Research Reviews ›
-
Ingbar and Braverman’s historic study of LT4 monotherapy
December 21, 2020
-
Prevalence rates for 10 chronic disorders at various FT4, TSH and FT3 levels
October 21, 2020
-
Japanese thyroid scientists examine symptoms in relation to FT3 and TSH
March 11, 2020
Testing policy ›
-
How can clinical biochemists help or harm thyroid patients?
March 2, 2020
-
Survey: Canadian Thyroid Testing Tips & Challenges
December 19, 2019
-
Relational Stability, Part 2: Normality of TSH and thyroid hormones
December 15, 2019